Ask a Question

User facetoad1

Member for: 5 days (since Aug 19)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/acy-775.html
About: Cost-effectiveness of pertuzumab and also trastuzumab biosimilar mix therapy since first strategy for HER2-positive advanced breast cancer in Singapore.

Activity by facetoad1

Score: 100 points (ranked #49)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for facetoad1

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...